Portfolio company
Concord Biomedical Sciences and Emerging Technologies, Inc.
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides preclinical research, testing and histopathology services to the medical device, pharmaceutical, diagnostic and biotechnology industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CBSET
This company provides preclinical research and product development services for medical device, pharmaceutical, diagnostic and biomedical research organisations.
Meridien Research
This company provides clinical trial site services to pharmaceutical and biotechnology sponsors for testing investigational medications and medical devices across various therapeutic areas.
Precision for Medicine
This company provides biomarker-driven clinical research and development services for pharmaceutical and biotechnology organisations to accelerate the commercialisation of personalised medicines.
Everest Clinical Research
The company provides clinical research and trial support services to pharmaceutical, biotechnology and medical device industries.
AIM Biotech
This company develops organ-on-a-chip microfluidic platforms and research services for pharmaceutical firms and academic researchers to conduct preclinical human-tissue drug testing.
MI Bioresearch
This contract research organisation provides preclinical oncology imaging and pharmacology services to pharmaceutical and biotechnology companies.
OCR
This company provides clinical research services using canine models to test drug candidates for pharmaceutical and biotechnology organisations.
Clyde Biosciences
This company provides cardiac safety and efficacy testing services for pharmaceutical and biotechnology organisations using its proprietary cell-based assay platform.
